Concepedia

Benjamin Ory

BO

38

Publications

2.2K

Citations

29

H-Index

2005

Active since

Affiliations

Inserm(Current)

Nantes Université

Centre Hospitalier Universitaire de Nantes

Institut de Cancérologie de l'Ouest

Harvard University

Benjamin Ory is an author at Inserm specializing in medicine, cell biology, and tumor biology.

ORCID

Top concepts

Publications per year

2005–2024

38

Publications

38

Zoledronic acid suppresses lung metastases and prolongs overall survival of osteosarcoma‐bearing mice

Benjamin Ory, Marie‐Françoise Heymann, Akira Kamijo et al. · Cancer · 2005 · 160 citations · Full text

Identification of genomic differences among peripheral arterial beds in atherosclerotic and healthy arteries

Marja Steenman, Olivier Espitia, Blandine Maurel et al. · Scientific Reports · 2018 · 155 citations · Full text

Selective inhibition of BET bromodomain epigenetic signalling interferes with the bone-associated tumour vicious cycle

François Lamoureux, Marc Baud’huin, Lidia Rodriguez Calleja et al. · Nature Communications · 2014 · 142 citations · Full text

, , +12

Enhanced tumor regression and tissue repair when zoledronic acid is combined with ifosfamide in rat osteosarcoma

Dominique Heymann, Benjamin Ory, Frédéric Blanchard et al. · Bone · 2005 · 133 citations

, , +9

FGFR2 signaling underlies p63 oncogenic function in squamous cell carcinoma

Matthew R. Ramsey, Catherine Wilson, Benjamin Ory et al. · Journal of Clinical Investigation · 2013 · 110 citations · Full text

, , +13

Rows per page

1–5 of 38